<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_ShanghaiTechChina_B_Project_Intestinal_Disease skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:ShanghaiTechChina B/Project/Intestinal Disease</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV id="navbar" class="collapse navbar-collapse"><UL class="nav navbar-nav navbar-right"><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B">Home</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2016.igem.org/Team:ShanghaiTechChina_B/Project">Project</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Project#Intestinal_Disease">Intestinal Disease</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Project#EGF_Expression">EGF Expression</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Project#Therapeutic_Biofilm">Therapeutic Biofilm</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Project#NO_Sensor">NO Sensor</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Project#Quorum_Sensing">Quorum Sensing</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Project#Kill_Switch">Kill Switch</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Project#Warship">Warship</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Project#Model">Model</A></LI></UL><LI class="dropdown"><A class="dropdown-toggle" href="https://2016.igem.org/Team:ShanghaiTechChina_B/Lab_Work">Lab Work</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Lab_Work#Parts">Parts</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Lab_Work#Safety">Safety</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Lab_Work#Protocols">Protocols</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Lab_Work#Notebook">Notebook</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2016.igem.org/Team:ShanghaiTechChina_B/Human_Practice">Human Practice</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Human_Practice#Introduction">Introduction</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Human_Practice#Interviews">Interviews</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Human_Practice#Survey">Survey</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Human_Practice#Social Media">Social Media</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Human_Practice#HUST_Cheering">HUST-Cheering</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Human_Practice#iDPI">iDPI</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Human_Practice#Poster">Poster</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2016.igem.org/Team:ShanghaiTechChina_B/Collaborations">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Collaborations#SYSU_MEDICINE">SYSU-MEDICINE</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Collaborations#FAFU_CHINA">FAFU-CHINA</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2016.igem.org/Team:ShanghaiTechChina_B/About_Us">About Us</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/About_Us#Team Roster">Team Roster</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/About_Us#Acknowledgement">Acknowledgement</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/About_Us#Attributions">Attributions</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="#" data-toggle="dropdown">Judging</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Attributions">Attributions</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Collaborations">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/HP/Silver">HP Silver</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/HP/Gold">HP Gold</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Description">Description</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Proof">Proof</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Demonstrate">Demonstrate</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Integrated_Practices">Integrated Practices</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Model">Model</A></LI><LI><A href="https://2016.igem.org/Team:ShanghaiTechChina_B/Hardware">Hardware</A></LI></DIV></DIV><DIV class="container"><DIV class="row"><DIV class="col-md-12"><DIV class="bs-docs-section"><H1>Intestinal Diseases</H1><P>The intestines, which are responsible for digestion and absorption, are a crucial part of the gastrointestinal tract in the human body. There are many diseases affecting our gastrointestinal system, which jeopardize our health. </P><P>Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, are an inflammatory condition affecting the bowel linings. Crohn's disease affects about 3.2 per 1,000 people in Europe and North America. Unfortunately, mechanisms of IBD remain a riddle, and scientists spare no effort to seek effective therapies.</P><P>We conducted a survey regarding inflammatory bowel disease awareness and found out that a lot of us are suffering from these diseases. People in China are still not paying enough attention to intestinal diseases. Our team iGEM2016 ShanghaiTechChina_B is striving to change this situation. We chose IBD as an entry point and designed a complete set of therapeutic methods to treat it by utilizing our engineered E.coli. Actually we are hoping to build a platform that may also be applied to other intestinal diseases in the future.</P><P>We hope that our work can help more patients who are suffering from intestinal diseases, and raise the attention of public. This is the fundamental principle of our human practice.</P><P>There are currently four methods to treat IBD: surgery, chemical drugs, immunosuppression, fecal microbiota transplant. It is unfortunate that all of these treatments have limited effects on IBD.</P><H3>Surgery</H3><P>Ulcerative colitis can in most cases be cured by proctocolectomy, although this may not eliminate extra-intestinal symptoms.</P><P>Surgery cannot cure Crohn's disease but may be needed to treat complications such as abscesses, strictures or fistulae. Crohn's disease can recur in the healthy parts of the intestine, usually at the resection site. </P><H3>Chemical Drugs</H3><P>Chemical drugs for IBD are tailored for each patient.  So doctors must consider various factors to determine drugs and doses.</P><H3>Immunosuppression</H3><P>Generally, depending on the level of severity, IBD may require immunosuppression to control the symptoms. The side effect is that the body becomes more vulnerable to infections and malignancy.</P><P>Fecal microbiota transplant</P><P>FMT is the process of transplantation of fecal bacteria from a healthy individual into a recipient. It is a relatively new treatment option for IBD which has attracted many attention since 2010 and many related standards has not been completely established yet.  This therapy needs strict tests for donors, and the curative effect is not significant enough so far.</P><P>Reference:</P><P>[1] Karimuddin, Ahmer; Gilles, Gary. &quot;Surgery for Abdominal/Intestinal Crohn's Disease&quot;. Trusted Therapies. Trusted Therapies. Retrieved 19 May 2015.</P><P>[2] Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho GT, Satsangi J, Bloom S (2011). &quot;Guidelines for the management of inflammatory bowel disease in adults&quot;. Gut. 60 (5): 571–607. doi:10.1136/gut.2010.224154. PMID 21464096.</P><P>[3] Colman RJ, Rubin DT (2014). &quot;Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis&quot;. J Crohns Colitis. 8 (12): 1569–81. doi:10.1016/j.crohns.2014.08.006. PMC 4296742free to read. PMID 25223604.</P></DIV></DIV></DIV></DIV><FOOTER class="bs-docs-footer"><DIV class="container"><UL class="bs-docs-footer-links"><LI>iGEM2016</LI><LI>Copyright © 2016 ShanghaiTechChina_B iGEM Team</LI></UL></DIV></FOOTER></DIV></DIV></DIV></DIV></DIV></BODY></HTML>